BioAgilytix

Durham, United States Founded: 2008 • Age: 18 yrs Acquired By Cinven
Large-molecule bioanalysis is provided for biologics and biosimilars development.

About BioAgilytix

BioAgilytix is a Healthcare company based in Durham (United States) founded in 2008, and was acquired by Cinven in November 2021. Large-molecule bioanalysis is provided for biologics and biosimilars development. BioAgilytix has completed 4 acquisitions, including 360biolabs, Cambridge Biomedical and IPM Biotech. Its website bioagilytix.com draws about 42 thousand monthly visits. BioAgilytix offers products and services including Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Bioanalytical Services. Its legal entity is BIOAGILYTIX LABS, INC. Its competitors include Advion, Evans Analytical Group and ApoCell; 1 of its 3 listed competitors has raised funding.

Company details

BioAgilytix was founded in 2008 and is headquartered in Durham, North Carolina, within the Research Triangle Park area. Operations are conducted as a bioanalytical contract research organization in the biotechnology sector. Services encompass assay development, validation, and sample analysis for immunoassays and cell-based assays, performed under non-GLP, spirit-of-GLP, and GLP guidelines. GMP-compliant product release testing is also handled to support clinical trials for therapeutic biologics and biosimilars.

  • Headquarters Durham, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website bioagilytix.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by Cinven (Nov 2021)
  • Legal Name Bioagilytix Labs, Inc.
Key Metrics

Products & Services of BioAgilytix

BioAgilytix offers a comprehensive portfolio of products and services, including Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing.

Method Transfer
Bioanalytical Service

Streamlines processes for successful assay method transfers in development.

Assay Creation
Custom Development

Develops and validates custom assays for bioanalytical needs.

Sample Analysis
Testing Service

Provides accurate analysis of samples for preclinical and clinical trials.

Kit Production
Support Service

Produces customized specimen collection kits for clinical trials.

Diagnostic Testing
Biomedical Service

Offers testing for infectious diseases and immunology diagnostics.

Apps and channels of BioAgilytix

its YouTube channel BioAgilytix has 457 subscribers and 30 videos.

BioAgilytix
YouTube 457 subscribers 30 videos Science & Technology
Open channel

Videos from BioAgilytix

The most watched videos on BioAgilytix's YouTube channel, BioAgilytix (457 subscribers). Click a video to play it here.

How does Droplet Digital PCR work? | Science in 60 Seconds
6.8K views
What is SIMOA and how does it work? | Science in 60 Seconds
6K views
[Podcast] Dr. David Johnson Talks Frosted Flakes, Small Molecules, and Pharmacokinetics!
2K views
How are ELISpot assays used for immunogenicity testing? | Science in 60
1.6K views

More on BioAgilytix.

Funding Insights of BioAgilytix

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of BioAgilytix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2019Series A–GHO Capital Partners
–
Valuation history

4 investors in total: 4 institutional.

Investors in BioAgilytix

BioAgilytix has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include GHO Capital, Riverside Partners and Cobepa.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Specialist healthcare investment advisory services are provided by GHO Capital.
ghocapital.comLondon, United Kingdom
Private equity investments are made in technology and healthcare sectors.
riversidepartners.comBoston, United States
Cobepa is recognized as an independent investment company.
cobepa.comBrussels, Belgium
Private equity investments and portfolio management services are provided by Cinven across various sectors.
cinven.com
Premium access

Investor details for BioAgilytix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BioAgilytix

154 people are tracked at BioAgilytix (48 in leadership, 106 in team).

NameRoleGroup
Stephane De Fortescu
VP, Business Development in EuropeLeadership
Michelle Mason
Director, Project ServicesLeadership
Kevin J. Burns
Director, Business DevelopmentLeadership
Scott Geller
Vice President Of Finance And OperationsLeadership
Euan Menzies
Chairman & CEOLeadership
Linda Robbie
COOLeadership
Teresa Neal
Head Of Global ProcurementLeadership
Marco Klinge
Associate Director Bioanalytical OperationsLeadership
Maureen Marchek
CFOLeadership
Alistair Draffan
President, 360biolabsLeadership
Kathryn Lindley
VP & General Manager, BioAgilytix DurhamLeadership
Thomas J. Schneider
Director, Scientific ServicesLeadership
Jeffrey Patrick
Sr DirectorLeadership
Robert Nelson
Scientific Officer, Senior DirectorLeadership
Natalie Smith
CLIA Laboratory DirectorLeadership
Jennifer M. Zemo
Vice President Quality AssuranceLeadership
Shashank Gorityala
Associate Director, Head Of Large Molecule Mass Spectrometry Core Services, Bioanalytical SciencesLeadership
Jennifer T Durham
Associate Director Of Scientific ServicesLeadership
Mark Spengler
Senior Director Business DevelopmentLeadership
Sarah Rieveschl
Executive Director, Strategic AccountsLeadership

134 more people are available in the full profile.

Premium access

Complete people profiles for BioAgilytix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BioAgilytix

BioAgilytix has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include 360biolabs, Cambridge Biomedical and IPM Biotech.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
CRO specialising in bioanalysis & DMPK assays
microconstants.comSan Diego, United States1998Aug 2021••••
Contract virology and immunology services are provided by 360biolabs.
360biolabs.comMelbourne, Australia2015Aug 2021••••
Bioanalytical and diagnostic testing services are provided for life sciences.
cambridgebiomedical.comBoston, United States1997Nov 2019••••
Biomarkers, cytometry, PCR, and ELISA machines are manufactured.
ipm-biotech.deHamburg, Germany2008Feb 2016••••
Premium access

Complete acquisition details for BioAgilytix

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of BioAgilytix

9 dated milestones of BioAgilytix across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioAgilytix is founded.
  2. Exit Acquired by Riverside Partners.
  3. Acquisition Acquires IPM Biotech.
  4. Exit Acquired by Cobepa.
  5. Funding First funding round.
  6. Acquisition Acquires Cambridge Biomedical.
  7. Acquisition Acquires 360biolabs.
  8. Acquisition Acquires MicroConstants.
  9. Exit Acquired by Cinven.

Competitors of BioAgilytix

BioAgilytix has 3 listed competitors in our database, 1 of them funded. They include Advion, Evans Analytical Group and ApoCell.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
advion.com1993Ithaca, United States$45.64M54
Microfluidics and mass spectrometry products are provided for clinical research.
eag.com1978San Diego, United States601
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
apocell.com2004Houston, United States2,198
Provider of clinical trial and clinical development on bioanalytical services
Premium access

Detailed competitors of BioAgilytix

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of BioAgilytix

The website of BioAgilytix (bioagilytix.com) receives about 41.6K visits a month and ranks #919,146 among all websites worldwide, #1,107 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    41.6K

    ▲ 16.4% vs previous month

  • Unique visitors
    16.3K

    per month

  • Global rank
    #919,146

    among all websites

  • Category rank
    #1,107

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with BioAgilytix. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
sherlock.bio
100%
2.8K#4,929,420View details
vividion.com
99%
4.3K#4,498,113View details
ornatx.com
99%
4.4K#3,250,511View details
nebiolab.com
99%
20.8K#944,903View details
cuebiopharma.com
98%
4.9K#7,063,180View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for BioAgilytix

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as BioAgilytix (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioagilytix

Premium access

Complete news archive for BioAgilytix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioAgilytix

BioAgilytix was founded in 2008 and raised its 1st funding round 11 years after it was founded.

BioAgilytix is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

BioAgilytix was founded in 2008 and is headquartered in Durham, North Carolina, within the Research Triangle Park area. Operations are conducted as a bioanalytical contract research organization in the biotechnology sector. Services encompass assay development, validation, and sample analysis for immunoassays and cell-based assays, performed under non-GLP, spirit-of-GLP, and GLP guidelines. GMP-compliant product release testing is also handled to support clinical trials for therapeutic biologics and biosimilars.

BioAgilytix's top competitors include Advion, ApoCell and Evans Analytical Group.

BioAgilytix offers Method Transfer, Assay Creation, Sample Analysis, Kit Production, and Diagnostic Testing.

BioAgilytix has made 4 acquisitions, including 360biolabs, Cambridge Biomedical, and IPM Biotech.

BioAgilytix has 4 investors. Key investors include GHO Capital, Riverside Partners, Cobepa, and Cinven.

BioAgilytix operates through Bioagilytix Labs, Inc..

Yes. BioAgilytix was acquired by Cinven in November 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available